Stockreport

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock [Yahoo! Finance]

Valneva SE - American Depositary Shares  (VALN) 
PDF Currently approved for adults, the vaccine may soon be accessible to adolescents aged 12 to 17 years, following the label extension. This submission is backed by posit [Read more]